Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

Hesley Group seeks to move on from troubled past with 60 new adult homes

UK for-profit specialist care provider Hesley Group is attempting to chart a new course and move on from its troubled past with plans for 60 new adult care homes to be built by 2030. The Yorkshire-based operator was hit with a major abuse scandal and police investigation in 2022, and then bought by Blandford Capital, a UK private equity firm that helps companies through ‘special situations’, in 2023.

AstraZeneca plans to invest $15 billion in China

Global pharmaceutical company AstraZeneca is set to make a $15 billion investment in China through 2030 to expand its manufacturing and research and development capabilities in the country.

Interview: Jason Powell, CEO of UK Vein Clinic

HBI talks to Jason Powell, CEO of UK Vein Clinic, a low-cost outpatient chain for vericose vein treatment on the company's national expansion and the UK vein care market. UK Vein Clinic has announced plans to expand its network, with the launch of 17 new clinics in 2026.

Siegfried acquires Noramco, Extractas Biosciences, and Purisys from SK Capital

Siegfried, a Switzerland-headquartered pharma Contract Development and Manufacturing Organisation (CDMO), is acquiring three businesses from private equity firm SK Capital: the pharma company Normaco Group, Purisys, a CDMO partner for custom APIs, and Extractas Bioscience, a Tasmania-based botanicals manufacturer.

Bupa and HCF likely to lobby against Ramsay’s acquisition of NCPH from Healthscope

Private health insurer Bupa and publicly listed not-for-profit insurer HCF are reportedly preparing to lobby the Australian Competition and Consumer Commission (ACCC) to block the acquisition of Canberra-based National Capital Private Hospital (NCPH) by Australia’s largest for-profit hospital group, Ramsay Health Care.

Find Us